+49 2066 50687-70

Noscendo – tHe company

About us

Noscendo GmbH is the leading global provider of software-based pathogen identification technology. We’ve made it our objective to revolutionise infection diagnostics, thus saving patient lives.

Scores of well-known university hospitals, major regional hospitals and hospital groups are already using DISQVER. We also work with several health insurance providers.

We have already received a host of awards for our pioneering approach. Noscendo was named Health-i Pioneer 2020 by Handelsblatt and Techniker Krankenkasse (TK). The award honours highly innovative ideas in the healthcare sector. In 2019, the scientific project behind DISQVER was awarded the ‘SIK Innovation Prize 2019’ by the Stuttgart Intensive Care Congress (SIK).

DISQVEr together!

Noscendo in numbers

2017

Noscendo founded

2019

Approval of DISQVER analysis platform

2

Sites, Tübingen and Duisburg

News

newsEN
Heiner Dreismann joins Noscendo’s Board of Directors

Noscendo GmbH, a leading diagnostic company for identification and assessment of bloodstream associated pathogens and other infections announced today the addition of Heiner Dreismann, former President and CEO of Roche Molecular Systems, to its Board of Directors

Team

Dr. Jennifer Axnick

Dr. Jennifer Axnick

Technical Key Account Manager

Dr. Marcus Benz

Dr. Marcus Benz

Chief Operating Officer

Tobias Bernhardt

Tobias Bernhardt

Technical Employee

Daniel borda-molina

Daniel borda-molina

Bioinformatician

Julia Bottlang

Julia Bottlang

Technical Employee

Nico Büker

Nico Büker

Software Developer

ALI CELIK

ALI CELIK

IT Admin

Sebastian Clanzett

Sebastian Clanzett

Vice President Bio & Information Technology

Dr. Frauke Diekmann

Dr. Frauke Diekmann

Key Account Manager

Dr. Claudia Disque

Dr. Claudia Disque

Enabling Engineer

Robert Fox

Robert Fox

Software Developer

Dr. Silke Grumaz

Dr. Silke Grumaz

Chief Scientific Officer, Co-Founder

Dr. Peter Haug

Dr. Peter Haug

Chief Strategy Officer, Co-Founder

Renè Hennig

Renè Hennig

Senior Software Developer

Maximiliane Häußinger

Maximiliane Häußinger

Customer Success Agent

Ian Hill

Ian Hill

Development Manager

DR. BETTINA HOFER

DR. BETTINA HOFER

Medical Project Management

Dr. Rafael Holzem

Dr. Rafael Holzem

Quality Management Representative

Dr. Petra Horvatek

Dr. Petra Horvatek

Customer Success Agent

Sabine Kießling-Parr

Sabine Kießling-Parr

Key Account Manager

UTA Kossatz-Böhlert

UTA Kossatz-Böhlert

Teamlead Clinical Trials

Dr. Sonia Mazitelli

Dr. Sonia Mazitelli

Technical Employee

Christian Lohmann

Christian Lohmann

Head of Sales

Michelle Menges

Michelle Menges

Technical Employee

MARKUS MOOCK

MARKUS MOOCK

Research Assistant

Ulrike Neder

Ulrike Neder

Bioinformatician

Marco Pietschmann

Marco Pietschmann

Vice President Digital Integration

Philip Pohl

Philip Pohl

Technical Employee

Peter Rademacher

Peter Rademacher

Development Manager

Joshua Richenhagen

Joshua Richenhagen

Software Developer

Jörg Schäfer

Jörg Schäfer

Requirements Engineer

Dr. Philip Stevens

Dr. Philip Stevens

Chief Executive Officer, Co-Founder

Damir Turcinovic

Damir Turcinovic

Software Developer

Dr. Sandra Unsleber

Dr. Sandra Unsleber

Scientist for NGS-based diagnostics

Maria Watters

Maria Watters

Chief Commercial Officer

Strategic And Scientific Advisory Board

Prof. Dr. Arndt von Haeseler

Prof. von Haeseler is Head of CIBIV (Center for Integrative Bioinformatics Vienna) at the Max Perutz Labs, where he also served as the scientific director. In 2015, von Haeseler was elected as a corresponding member in Austria of the mathematics and science class of the Austrian Academy of Sciences.

Dr. Trevor Hawkins

Dr Hawkins’ 25+ year career in healthcare has included business, academic innovation and entrepreneurship. Dr Hawkins was previously Director of the Human Genome Project for the US DOE, and has held senior executive roles at Siemens Healthcare, Philips, GE Healthcare and Amersham.

Dr. Michael Lutz

Dr Lutz is an experienced biotech entrepreneur who has spent the last 15 years leading several life sciences companies until their successful exit. Before he was appointed CEO/Managing Director of HepaRegeniX in 2019, he built and led LifeCodexx as the leading cfDNA-based NIPT provider from inception to reimbursement in several European countries. Dr Lutz holds a PhD in Bioorganic Chemistry from ETH Zurich (Switzerland).

Prof. Dr. James Rothman

Prof. Rothman is a highly distinguished biochemist and Sterling Professor of Cell Biology at Yale University who was awarded the 2013 Nobel Prize in Physiology/Medicine. Prof. Rothman serves, among other positions, as Chair of the Yale School of Medicine’s Department of Cell Biology and is the Director and founder of the Nanobiology Institute on Yale’s new West Campus.

Prof. Dr. Felix Wieland

Prof. Wieland is an elected Member of the Academia Europea and the National Academy of Sciences, Leopoldina, as well as an honorary member of the Charité (Medical Faculty of Humboldt University Berlin) and is a Senior Professor for Biochemistry at Heidelberg University. Prof. Wieland’s main areas of research are Enzymology, Glycobiology and Molecular Membrane Biology, including the specificity of lipid-protein interactions.

Information for physicians

More precise diagnostics – more knowledge: Find out more about the clinical use of DISQVER!

How DISQVER works

Information for medical disciplines

Publications

News

Read more about Noscendo and DISQVER or visit us at trade fairs and conferences!

All News

Publications

Events

Press

Company

DISQVER together – get to know Noscendo!

Noscendo

Team

Advisory Board

Career